BOBA:CRYPTOCAPMarket Cap BOBA, $ Analysis
Data as of 2026-03-12 - not real-time
IDR 156.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
PT Formosa Ingredient Factory Tbk (BOBA.JK) is trading at its 156 IDR support level, well below the 20‑day (175.7), 50‑day (179.2) and 200‑day (182.6) SMAs, indicating a pronounced bearish price trend. Technical signals reinforce this view: the 14‑day RSI sits at 28, suggesting the stock is oversold, while the MACD line is negative and its histogram remains in bearish territory. Volume is increasing, which could provide the momentum needed for a short‑term bounce, but the 30‑day volatility of ~36% and a max drawdown of nearly 31% highlight sizable price swings. On the fundamentals side, the company posts a healthy 7.9% revenue growth, solid gross (32%) and operating (22%) margins, and a low PE of 9.2, positioning it well below its DCF‑derived fair value of 173 IDR. The balance sheet is strong with a debt‑to‑equity of 0.19, ample cash (16.3 bn IDR), and a generous dividend yield of 4.49%, suggesting dividend sustainability. Overall, while the short‑term chart remains bearish, the valuation gap, defensive consumer sector positioning, and robust cash flow make BOBA an attractive value play with upside potential toward its fair value.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is at the identified support level of 156 IDR
- RSI indicates oversold conditions but MACD remains bearish
- High dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value (173 IDR) is substantially above current price
- Strong cash generation and low leverage support earnings stability
- Defensive consumer sector reduces earnings volatility
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable dividend backed by solid free cash flow
- Low beta (0.19) indicates limited market‑wide risk exposure
- Consistent revenue growth and attractive valuation multiples
Key Metrics & Analysis
Financial Health
Revenue Growth7.90%
Profit Margin11.28%
P/E Ratio9.2
ROE12.72%
ROA9.11%
Debt/Equity0.19
P/B Ratio1.1
Op. Cash FlowIDR30.8B
Free Cash FlowIDR9.5B
Technical Analysis
TrendBearish
RSI28.2
SupportIDR 156.00
ResistanceIDR 222.00
MA 20IDR 175.70
MA 50IDR 179.18
MA 200IDR 182.57
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16
Valuation
Fair ValueIDR 173.10
GradeUndervalued
TypeBlend
Dividend Yield4.49%
Risk Assessment
Beta0.19
Volatility35.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.